![]() |
|
|
Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, National Institutes of Health
| |
Abstract |
|---|
|
|
|---|
Phenolphthalein, a widely used laxative, is the active ingredient
in more than a dozen commercial nonprescription formulations. Fast-flow
EPR studies of the reaction of phenolphthalein with horseradish
peroxidase (HRP) and hydrogen peroxide permit the direct detection of
two free radicals. One has EPR parameters characteristic of phenoxyl
radicals. The other has a broad unresolved spectrum, possibly arising
from free radical polymeric products of the initial phenoxyl radical.
EPR spin-trapping studies of incubations of phenolphthalein with
lactoperoxidase, reduced glutathione (GSH), and hydrogen peroxide with
5,5-dimethyl-1-pyrroline N-oxide (DMPO) demonstrate
stimulated production of DMPO/
SG compared
with an identical incubation lacking phenolphthalein. In the absence of
DMPO, measurements with a Clark-type oxygen electrode show that
molecular oxygen is consumed by a sequence of reactions initiated by
the glutathione thiyl radical. Enhanced production of DMPO superoxide
radical adduct is also found in a system of phenolphthalein, NADH, and
lactoperoxidase. In this system the phenolphthalein phenoxyl radical
abstracts hydrogen from NADH to generate
NAD
, which is not spin trapped by DMPO, but
reacts with molecular oxygen to produce the superoxide radical detected
by EPR. In the absence of DMPO, the oxygen consumption is measured
using the Clark-type electrode. Production of ascorbate radical anion
is also enhanced in a system of phenolphthalein, ascorbic acid,
hydrogen peroxide, and lactoperoxidase. Ascorbate inhibits oxygen
consumption when phenolphthalein is metabolized in the presence of
either glutathione or NADH by reducing radical intermediates to their parent molecules and forming the relatively stable ascorbate anion radical. The detection of enhanced free radical production in these
three systems, a consequence of futile metabolism (or redox cycling),
suggests that phenolphthalein may be a significant source of oxidative
stress in physiological systems. Parallel EPR and oxygen consumption
studies with phenolphthalein glucuronide give analogous results, but
with lesser enhancement of free radical production.
| |
Introduction |
|---|
|
|
|---|
Phenolphthalein, a triphenylmethane derivative (fig. 1), is widely used as a laxative and cathartic agent and is the active ingredient in many commercial products that are available for use (and possible abuse by some bulimics) as over-the-counter, nonprescription formulations (1-4). A recent report of the National Toxicology Program found evidence that phenolphthalein was a carcinogen based on 2-yr feeding studies (5). Earlier subchronic toxicity studies of phenolphthalein given orally to rats and mice in food found little evidence of toxicity in rats but did find toxic effects in mice. Changes found in the mouse reproductive system included depressed testis and right epididymal weights and sperm density, elevated production of abnormal sperm, and morphological changes in seminiferous tubules. Hematopoietic changes included bone marrow hypoplasia, increased splenetic hematopoiesis in males, and an elevated incidence of micronucleated erythrocytes (6, 7).
|
The pharmacology
dosage, absorption, distribution, biotransformation,
and excretion
of phenolphthalein and related diphenylmethane laxatives
has been reviewed (5, 8). Phenolphthalein is believed to function as a
laxative by stimulating the synthesis and release of prostaglandins, as
suggested by the ability of prostaglandin inhibitors such as aspirin
and indomethacin to inhibit the laxative action of phenolphthalein in
mice (9). At ordinary dose levels, phenolphthalein appears to be
metabolized to its glucuronide conjugate in the intestinal lumen and
the liver and excreted largely as the glucuronide. Animal studies have
shown that phenolphthalein is excreted almost entirely in the bile as
phenolphthalein glucuronide (>98%) (10-12). Phenolphthalein is
glucuronidated in intestinal mucosa at an activity about 20% of that
in the liver on a per gram of organ basis (13). When either
phenolphthalein or phenolphthalein glucuronide was administered iv to
male rats, they were both rapidly excreted in bile as the glucuronide
conjugate. At dose levels of 30 mg phenolphthalein, 99.6% was excreted
as phenolphthalein glucuronide and 0.4% as phenolphthalein itself
(14).
The extent and duration of phenolphthalein laxation seems to be enhanced by extensive enterohepatic recirculation after hydrolysis of the glucuronide by bacterial glucuronidase in the intestine. In experiments with [3H]phenolphthalein administered to female Wistar albino rats, 90% was eliminated predominantly as the glucuronide within 3 hr after ip injection; return of labeled phenolphthalein glucuronide to duodena of bile-duct-cannulated animals demonstrated 85% enterohepatic recirculation in 24 hr. Pretreatment of animals with antibiotics to suppress intestinal microflora decreased the enterohepatic recirculation rate to 22% (15).
The phenolic substituents of phenolphthalein (fig. 1) make it a likely candidate for peroxidase metabolism(scheme 1), which provided the impetus for the present study. Similar reactions with phenolic compounds are well known, with free radical intermediates having been detected with EPR during peroxidase-catalyzed metabolism (16-22). Lactoperoxidase is a typical mammalian peroxidase found in milk, saliva, and tears as well as the mammary glands, and has a biochemistry resembling that of HRP2 and many other peroxidases. In general, mammalian peroxidases are activated to compound I enzyme intermediates by hydrogen peroxide, which can subsequently oxidize many phenolic substrates to their corresponding free radicals (23).
|
|
Phenoxyl radical metabolites can react with suitable biochemical reductants such as GSH and NAD(P)H to regenerate the parent phenolic compound and a reductant-derived radical such as GS· or NAD· which reacts to form superoxide (24). Therefore, one molecule of phenol can undergo multiple cycles of oxidation and reduction in a process termed "futile metabolism," with the concomitant production of superoxide in quantities that greatly exceed the concentration of the phenolic compound.
Since both phenolphthalein and its glucuronide have phenolic groups that are likely to be substrates for peroxidases and since the exposure of phenolphthalein and its glucuronide to endogeneous peroxidases is likely to be extended by extensive enterohepatic recirculation, we have undertaken in vitro studies to investigate the possible peroxidase metabolism of phenolphthalein and its glucuronide to phenoxyl radicals with the associated production of biochemical reductant-derived free radicals and superoxide.
Materials and Methods
Chemicals and Biochemicals.
Ascorbic acid, ACS Reagent Grade, DTPA, GSH, HRP [EC 1.11.1.7], NADH,
and phenolphthalein glucuronic acid sodium salt were purchased from
Sigma Chemical Co. (St. Louis, MO) and were used as received.
Phenolphthalein was obtained from Fisher (Raleigh, NC). Catalase (from
beef liver, 65,000 U/mg crystalline suspension in water) and superoxide
dismutase (SOD; from bovine erythrocytes, 3000 U/mg lyophilizate
according to the method of McCord and Fridovich (25)) were purchased
from Boehringer-Mannheim (Indianapolis, IN) and were used as received.
The spin trap DMPO, also purchased from Sigma, was vacuum-distilled
twice at ambient temperature and stored at
70°C until use.
Lactoperoxidase [EC 1.11.1.7] (LPO; from bovine milk, 87 U/mg) was
purchased from Worthington Biochemical Corporation (Freehold, NJ) and
was used as received. The buffer for all reactions was 100 mM enzyme
grade tris(hydroxymethyl)-aminomethane (Bethesda Research Laboratories,
Bethesda, MD) adjusted to pH 7.4 with hydrochloric acid (Tris-HCl). The
Tris-HCl buffer was treated with Chelex 100 resin (Bio-Rad, Hercules,
CA) to remove adventitious transition metal ions and contained 50 µM
DTPA as a further precaution against trace metal catalysis.
Electron Spin Resonance (EPR) Experiments. Room-temperature EPR spectroscopy was used to detect and identify free radical intermediates formed during reactions. Although some of the free radicals in these experiments were too short lived to be detected directly in static incubations, certain intermediates were detected using the spin-trapping technique. The DMPO spin trap was present in all experiments (unless otherwise specified) to react with the short-lived free radical intermediate to form a relatively long-lived DMPO radical adduct. The original free radical intermediate was then identified by the resulting EPR hyperfine coupling constants of its DMPO adduct.
Direct detection of the unstable phenolphthalein phenoxyl radical was accomplished by fast-flow EPR experiments that were performed as described previously (18,19). From a height of 1.8 meters, reagents placed in 4-liter reservoirs were allowed to flow through plastic hoses to a quartz fast-flow mixing chamber flat cell (Type WG-804, modified flat cell, 17 mm width, Wilmad Glass Co., Buena, NJ) at rates controlled by Gilmont compact flowmeters. EPR measurements were made using a Bruker ER200-D electron spin resonance spectrometer operating at a microwave frequency near 9.7 GHz and a magnetic field of approximately 3480 Gauss, with magnetic field modulation at 100 kHz providing the usual first derivative display of the EPR spectrum. Samples were aspirated into a quartz flat cell prepositioned in a Bruker TM-110 cavity for EPR detection (26). Spectra were recorded on an interfaced IBM-compatible personal computer using locally produced software for data acquisition, analysis, and simulation (27). EPR figures were prepared using the Corel Corporation CorelDRAWTM software.Oxygen Consumption Experiments. Oxygen consumption measurements were made using a Clarke-type oxygen electrode fitted to a 1.8 ml Gilson sample cell and monitored by a Yellow Springs Instrument Company Model 53 oxygen monitor. Oxygen concentration in the samples as a function of time was recorded by a personal computer interfaced to the oxygen monitor with a Data Translation DT2801 data acquisition board. The oxygen consumption data were plotted by importing the ASCII data files into the Origin program (MicroCal Software, Inc., Northampton, MA).
| |
Results |
|---|
|
|
|---|
Direct EPR Observation of Radicals from Phenolphthalein Metabolism by HRP. A fast-flow reaction mixture containing phenolphthalein (fig. 1), HRP, and hydrogen peroxide produced EPR signals that seemed to be a superposition of spectra from two species (fig. 2A). Control studies demonstrated that no signal was observed in the absence of phenolphthalein (fig. 2D) or HRP (fig. 2E), and a much weaker signal was observed in the absence of added hydrogen peroxide (fig. 2C). Computer analysis of the composite spectrum showed it to be a relatively broad singlet (with peak-to-peak line width of 3.6 gauss) comprising 86% of the observed spectrum, while the remaining 14% resulted from a species with two sets of two equivalent hydrogen atoms with aH = 6.56 gauss and aH = 1.79 gauss, respectively. These parameters permitted a successful simulation of the composite spectrum (fig. 2B).
|
Phenolphthalein Metabolism in the Presence of Glutathione.
Glutathione thiyl free radical formation was mediated by
lactoperoxidase-catalyzed metabolism of phenolphthalein as demonstrated by spin-trapping with DMPO. A four-line EPR spectrum was observed in an
incubation that contained phenolphthalein, GSH, lactoperoxidase, and
hydrogen peroxide at pH 7.4 (fig. 3A).
Computer analysis and simulation of the characteristic four-line EPR
spectrum, corresponding to hyperfine coupling constants
aN = 15.1 and a
H = 16.2 G,
was consistent with formation of the DMPO/
SG (28, 29).
If phenolphthalein was not present in the incubation, DMPO/·SG was detected at a much lower concentration owing
to direct oxidation of GSH by lactoperoxidase (28, 29) (fig.
3B). In the absence of any of the incubation constituents
(GSH, DMPO, or lactoperoxidase), no free radicals were detected (figs.
3C, 3D, and 3E, respectively). The
omission of hydrogen peroxide resulted in a much lower concentration of
DMPO/
SG (fig. 3F). These EPR results are
consistent with the formation of a phenolphthalein phenoxyl metabolite
and the subsequent oxidation of GSH to its thiyl radical metabolite
(scheme 2).
|
SG (fig. 4E).
|
|
|
Phenolphthalein Metabolism in the Presence of NADH.
A reaction mixture containing NADH, phenolphthalein, lactoperoxidase,
and DMPO exhibited an EPR spectrum characteristic of the
DMPO/superoxide radical adduct (fig. 7A).
This spectrum could be simulated with hyperfine coupling constant
values in close agreement with those previously published (30, 31):
aN = 14.1, a
H = 11.3, and
a
H = 1.2 G. When phenolphthalein was omitted from
the reaction mixture, the DMPO/superoxide radical adduct decreased over
threefold (fig. 7B). No signal was detected in the absence
of either NADH (fig. 7C) or lactoperoxidase (fig.
7D). The signal was inhibited in a concentration-dependent
manner by catalase, which showed that trace amounts of hydrogen
peroxide, probably as a consequence of NADH autoxidation, were present
and required for the reaction (figs. 7E and 7F).
The generation of hydrogen peroxide in solutions of NADH has been noted
in other peroxidase investigations (32). DMPO/superoxide radical adduct
was inhibited in a concentration-dependent manner by SOD, with 5 U/ml
sufficient for ca. 60% inhibition (fig. 7G) and
98 U/ml sufficient for complete inhibition (fig. 7H).
|
|
|
Phenolphthalein Metabolism in the Presence of Ascorbate. Ascorbate is facilely oxidized by a one-electron transfer to produce the relatively stable ascorbate anion radical, which can be detected directly by its EPR spectrum. A reaction mixture of phenolphthalein, ascorbate, lactoperoxidase, and hydrogen peroxide gave a strong EPR spectrum that was characteristic of the ascorbate anion radical (fig. 10A). The observed two-line EPR spectrum had the characteristic hyperfine coupling constant aH = 1.79 G in agreement with the 1.76 G reported in the literature (34). When the reaction mixture included GSH, no change was observed in the EPR signal (fig. 10B), which indicated that the phenolphthalein phenoxyl radical reacted with ascorbate instead of GSH. When phenolphthalein was omitted from the incubation, the ascorbate anion radical decreased twofold (fig. 10C). Omission of lactoperoxidase from the reaction mixture (fig. 10D) produced only the residual ascorbate radical anion signal characteristic of the ascorbic acid solution in buffer (fig. 10G). Omission of ascorbate from the reaction mixture produced no EPR signal at all (fig. 10E), and omission of hydrogen peroxide from the incubation produced only a weak, transient EPR signal, presumably from trace amounts of hydrogen peroxide (fig. 10F). When the reaction occurred in the absence of added hydrogen peroxide but with added catalase (to remove traces of hydrogen peroxide), only the residual ascorbate radical anion signal was observed (fig. 11C). The presence of SOD in the reaction mixture had no effect on the EPR signal intensity (fig. 11D), which suggested that superoxide was not involved in the reactions that produce the ascorbate radical anion.
|
|
Metabolism of Phenolphthalein Glucuronic Acid.
Glutathione thiyl free radical was mediated by
lactoperoxidase-catalyzed metabolism of phenolphthalein glucuronide as
demonstrated by spin trapping with DMPO. As with phenolphthalein, a
four-line EPR spectrum of DMPO/·SG was observed in an
incubation that contained phenolphthalein glucuronide, GSH,
lactoperoxidase, and hydrogen peroxide (fig. 12A). If phenolphthalein glucuronide was not
present in the incubation, the DMPO/
SG was detected at a
lower concentration owing to the direct oxidation of GSH by
lactoperoxidase (28, 29) (fig. 12B). When any of the
incubation constituents (DMPO, GSH, or lactoperoxidase) was absent, no
free radicals were detected (figs. 12C, 12D, and
12E, respectively). The omission of hydrogen peroxide
resulted in a much lower concentration of DMPO/
SG (fig.
12F). These EPR results are consistent with the formation of
a phenolphthalein glucuronide phenoxyl metabolite and the subsequent oxidation of GSH to its thiyl radical metabolite.
|
|
|
| |
Discussion |
|---|
|
|
|---|
Phenolphthalein (fig. 1) has two phenolic substituents that would be expected to undergo reactions characteristic of phenols. When amines and phenols are oxidized in a peroxidase-hydrogen peroxide system, varied polymeric products are formed (35). Because the phenolic moieties of phenolphthalein lack substituents ortho to the hydroxyl function, phenolphthalein should be oxidized readily to relatively unstable phenoxyl free radicals by chemical and biochemical oxidizing agents. The EPR results for fast-flow studies of phenolphthalein oxidation by HRP (fig. 2A) confirmed the observation of a primary phenolphthalein phenoxyl radical. A large fraction (86%) of the observed signal was a result of a second species with a large line width and a predominantly Gaussian line shape. This signal probably arises from polymeric free radical species that were formed from the primary phenoxyl free radical. The smaller fraction (ca. 14%) of the observed signal arises from a phenoxyl radical with hyperfine coupling constants as follows: aoH = 6.56 G (2H) and amH = 1.79 G (2H). Typical literature values for phenoxyl hyperfine coupling constants are ca. 6 G for ortho protons and ca. 2 G for meta protons (36, 37), in close agreement with these results for the phenolphthalein system.
Evidence for the peroxidase-mediated metabolism of phenolphthalein to form phenoxyl radicals is supported by the direct EPR observation of a phenoxyl radical (fig. 2). Additional support is provided by EPR observations of the indirect consequences of phenoxyl radical production such as the production of glutathione thiyl (figs. 3 and 4), superoxide (fig. 7), and ascorbate radicals (figs. 10 and 11).
Scheme 1 represents the peroxidase-mediated metabolism of phenolphthalein to form phenolphthalein phenoxyl radicals. Each cycle of the peroxidase in scheme 1 results in the conversion of two phenolic substituents into phenoxyl radicals. If some subsequent reaction occurs to reform the original phenol species, the possibility for a cyclic chain reaction exists. In biological systems, the reducing equivalents required to reduce the phenoxyl radical can be provided by the endogenous reductants GSH, NADH, and ascorbate. Depletion of these species in vivo is evidence of oxidative stress. The extent of endogenous reductant free radical enhancement is seen in figs. 3, 7, and 10 by comparing the intensity of the EPR signal that is generated in the presence of phenolphthalein in the system with that generated in its absence. In the presence of endogenous reductants, the phenolphthalein phenoxyl radical is reduced to the parent compound, and subsequent product formation such as polymers will be prevented.
Scheme 2 outlines the sequence of possible reactions that can lead to oxidative stress (23). In the presence of GSH and in agreement with the scheme, metabolism of phenolphthalein led to enhanced formation of the glutathione thiyl radical and the stimulation of oxygen consumption in the glutathione/lactoperoxidase/hydrogen peroxide system. Some oxygen may also be consumed by the addition of the glutathione thiyl radical to oxygen to produce the glutathione peroxyl radical (GSOO·) (38, 39). Most glutathione thiyl radical is thought to react with another GSH (GS-) to form the glutathione disulfide radical anion, which then reacts with molecular oxygen to produce oxidized glutathione and superoxide radical anion (23).
When phenolphthalein is metabolized by lactoperoxidase in the presence of NADH, as described in scheme 2, more superoxide radical anion is trapped by DMPO than in a system lacking phenolphthalein (figs. 7A and 7B). Oxygen consumption in this system is suppressed at SOD concentrations as low as 0.075 U/ml, which indicates that superoxide is produced in a chain reaction mechanism. Phenolphthalein phenoxyl radical initiates the chain reaction by reacting with NADH to produce NAD·. On protonation, superoxide can oxidize additional NADH with a second-order rate constant of k = 1.8 × 105 M-1 s-1, thus producing NAD· and continuing the chain reaction (40). Other phenolic compounds such as scopoletin (31) and acetaminophen (41) are known to stimulate NADH oxidation by horseradish peroxidase.
When ascorbate is added to either the phenolphthalein/GSH/lactoperoxidase system or the phenolphthalein/NADH/lactoperoxidase system, oxygen consumption is prevented almost entirely if the addition is before initiation of the reaction or suppressed almost immediately if the addition is made after initiation of the reaction. Ascorbate radical anion production is found to increase in a phenolphthalein-dependent manner during the metabolism of phenolphthalein by lactoperoxidase. These observations are consistent with the formation of a phenolphthalein phenoxyl radical intermediate during the metabolism as shown in scheme 2. The ascorbate radical anion does not react with oxygen and, therefore, cannot contribute to increased oxidative stress.
The principal metabolite of phenolphthalein, phenolphthalein glucuronide, has a glucuronic acid moiety conjugated to one of the phenolic hydroxyl groups of phenolphthalein, while the second phenolic hydroxyl group remains unsubstituted and potentially available to form a phenoxyl radical. In these studies phenolphthalein glucuronide underwent reactions qualitatively similar to those observed for phenolphthalein itself. It stimulated the formation of glutathione thiyl radical, superoxide, and ascorbate radical anion and showed qualitatively the same oxygen consumption behavior as phenolphthalein (fig. 13). Although phenolphthalein glucuronide was significantly less active than phenolphthalein itself in these systems modeling oxidative stress (fig. 14), its in vivo concentration is over 100 times greater and either compound could be a source of in vivo free radical formation.
The reason for reduced activity of the glucuronide is not known, but Shiga and Imaizumi (17) reported that formation of phenoxyl radical by peroxidase oxidation depended not on the molecular sizes of the phenols but on their redox potentials. The presence of two oxidizable phenol groups in phenolphthalein, but only one in its glucuronide, is probably also a factor.
The results presented in these studies demonstrate that futile metabolism of micromolar quantities of phenolphthalein and phenolphthalein glucuronide can catalyze the oxidation of much greater concentrations of biochemical reducing cofactors such as ascorbate, glutathione, and NAD(P)H, with concomitant production of superoxide by subsequent reaction with oxygen of glutathione- and NAD(P)H-derived free radicals.
In the presence of catalytic SOD, superoxide is converted rapidly to hydrogen peroxide and molecular oxygen. The hydrogen peroxide so formed can react with peroxidases reinitiating the whole process (schemes 1 and 2). In the presence of reduced iron, the hydrogen peroxide thus produced can be a source of hydroxyl radical as a consequence of Fenton chemistry. Highly reactive hydroxyl radical has been found to react with DNA to produce many different products (42). In addition, oxygen-derived radicals have a pivotal role in tumor promotion (43-45). Although the facile free radical metabolism of phenolphthalein is suggestive, no evidence exists linking this free radical formation to the carcinogenicity of phenolphthalein.
The futile nature of this free radical metabolism, which does not lead to stable products, calls into question the very existence of this metabolism in vivo. In fact, no metabolites of phenolphthalein other than its glucuronide have been reported. Nevertheless, there is indirect evidence that phenolphthalein is an in vivo peroxidase substrate.
A number of investigations have found that phenolphthalein stimulates intestinal prostaglandin formation. In fact, the laxative effect of phenolphthalein is proposed to be the result of this increased prostaglandin formation (46-49). The ability of compounds to stimulate prostaglandin formation correlates directly with their ability to act as peroxidase substrates (50). The observation that phenolphthalein stimulates prostaglandin formation in vivo, thereby causing the laxative effect of phenolphthalein, is indirect evidence that phenolphthalein is metabolized to a phenoxyl free radical in vivo.
| |
Acknowledgment |
|---|
H. J. Sipe, Jr. gratefully acknowledges sabbatical leave support granted by the Professional Development Committee of Hampden-Sydney College, spring term 1996.
| |
Footnotes |
|---|
Received August 27, 1996; accepted January 20, 1997.
1 Permanent address: Department of Chemistry, Hampden-Sydney College, Hampden-Sydney, VA 23943.
Send reprint requests to: Ronald P. Mason, Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709.
| |
Abbreviations |
|---|
Abbreviations used are: DMPO, 5,5-dimethyl-1-pyrroline N-oxide; DTPA, diethylenetriaminepentaacetic acid; HRP, horseradish peroxidase; LPO, lactoperoxidase; SOD, superoxide dismutase.
| |
References |
|---|
|
|
|---|
| 1. | G. K. McEvoy: Cathartics and laxatives. In "AHFS Drug Information 95" (G. K. McEvoy, ed.), pp. 1986-1995. American Hospital Formulary Service (AHFS), American Society of Health System Pharmacists, Bethesda, MD, 1995. |
| 2. | American Medical Association: Laxatives and cathartics. In "AMA Drug Evaluations," 5th ed., pp. 1295-1309. American Medical Association, Chicago, IL, 1983. |
| 3. | American Society of Hospital Pharmacists: Diphenylmethane Laxatives. In "Drug Information 88," pp. 1628-1630. Am. Society of Hospital Pharmacists, Bethesda, MD, 1988. |
| 4. | L. L. Brunton: Agents affecting gastrointestinal water flux and motility, digestants, and bile acids. In "Goodman and Gillman's The Pharmacological Basis of Therapeutics" (A. G. Goodman, L. S. Goodman and A. Gilman, eds.), 8th ed., pp. 914-924. MacMillan, New York, 1990. |
| 5. |
J. K. Dunnick and
J. R. Hailey:
Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems.
Cancer Res.
56,
4922-4926 (1996) |
| 6. | D. D. Dietz, M. R. Elwell, R. E. Chapin, M. D. Shelby, M. B. Thompson, R. Filler, and M. A. Stedham: Subchronic (13-week) toxicity studies of oral phenolphthalein in Fischer 344 rats and B6C3F1 mice. Fundam. Appl. Toxicol. 18, 48-58 (1992)[Medline]. |
| 7. | K. L. Witt, D. K. Gulati, P. Kaur, and M. D. Shelby: Phenolphthalein: induction of micronucleated erythrocytes in mice. Mutation Res. 341, 151-160 (1995). |
| 8. | R. B. Sund: Aspects of the pharmacology of diphenylmethane laxatives (bisacodyl, oxyphenisatin, and phenolphthalein derivatives). Nor. Pharm. Acta 45, 125-162 (1983). |
| 9. | F. Capasso, N. Mascolo, G. Autore, and M. R. Duraccio: Suppression of laxative action of phenolphthalein by orally-administered indomethacin or aspirin. J. Pharm. Pharmacol. 36, 132-133 (1984)[Medline]. |
| 10. | P. Millburn, R. L. Smith, and R. T. Williams: Biliary excretion of foreign compounds. Biochem. J. 105, 1275-1281 (1967)[Medline]. |
| 11. | J. H. Gustafson and L. Z. Benet: Biliary excretion kinetics of phenolphthalein glucuronide after intravenous and retrograde biliary administration. J. Pharm. Pharmacol. 26, 937-944 (1974)[Medline]. |
| 12. |
Z. Gregus,
J. B. Watkins,
T. N. Thompson, and
C. D. Klaassen:
Depletion of hepatic uridine diphosphoglucuronic acid decreases the biliary excretion of drugs.
J. Pharmacol. Exp. Ther.
225,
256-262 (1983) |
| 13. | C. R. Short, M. D. Maines, and B. A. Westfall: Postnatal development of drug-metabolizing enzyme activity in liver and extrahepatic tissues of swine. Biol. Neonate 21, 54-68 (1972)[Medline]. |
| 14. | H. M. Mehendale: Assessment of hepatobiliary function with phenolphthalein and phenolphthalein glucuronide. Clin. Chem. Enzyme Comm. 2, 195-204 (1990). |
| 15. | R. J. Parker, P. C. Hirom, and P. Millburn: Enterohepatic recycling of phenolphthalein, morphine, lysergic acid diethylamide (LSD) and diphenylacetic acid in the rat: hydrolysis of glucuronic acid conjugates in the gut lumen. Xenobiotica 10, 689-703 (1980)[Medline]. |
| 16. | T. Shiga and K. Imaizumi: Generation of phenoxy radicals by methemoglobin-hydrogen peroxide studied by electron paramagnetic resonance. Arch. Biochem. Biophys. 154, 540-547 (1973)[Medline]. |
| 17. | T. Shiga and K. Imaizumi: Electron spin resonance study on peroxidase- and oxidase-reactions of horse radish peroxidase and methemoglobin. Arch. Biochem. Biophys. 167, 469-479 (1975)[Medline]. |
| 18. | P. D. Josephy, T. E. Eling, and R. P. Mason: Oxidation of p-aminophenol catalyzed by horseradish peroxidase and prostaglandin synthase. Mol. Pharmacol. 23, 461-466 (1983)[Abstract]. |
| 19. | P. R. West, L. S. Harman, and R. P. Mason: Acetaminophen: enzymatic formation of a transient phenoxyl free radical. Biochem. Pharmacol. 33, 2933-2936 (1984)[Medline]. |
| 20. | V. Fischer, L. S. Harman, P. R. West, and R. P. Mason: Direct electron spin resonance detection of free radical intermediates during the peroxidase catalyzed oxidation of phenacetin metabolites. Chem. Biol. Interact. 60, 115-127 (1986)[Medline]. |
| 21. | M. Valoti, H. J. Sipe, Jr., G. Sgaragli, and R. P. Mason: Free radical intermediates during peroxidase oxidation of 2-t-butyl-4-methoxyphenol, 2,6-di-t-butyl-4-methylphenol, and related phenol compounds. Arch. Biochem. Biophys. 269, 423-432 (1989)[Medline]. |
| 22. |
H. J. Sipe, Jr.,
S. J. Jordan,
P. M. Hanna, and
R. P. Mason:
The metabolism of 17 -estradiol by lactoperoxidase: a possible source of oxidative stress in breast cancer.
Carcinogenesis
15,
2637-2643 (1994) |
| 23. | D. N. R. Rao, W. D. Flitter, and R. P. Mason: The formation of free radical metabolites by mammalian peroxidases. In "Cellular Antioxidant Defense Mechanims" (C. K. Chow, ed.), vol. I, pp. 59-71. CRC Press, Boca Raton, FL, 1988. |
| 24. | R. P. Mason: Free radical metabolites of toxic chemicals and drugs as sources of oxidative stress. In "Biological Consequences of Oxidative Stress: Implications for Cardiovascular Disease and Carcinogenesis" (L. Spatz and A. D. Bloom, eds.), pp. 23-49. Oxford University Press, New York, 1992. |
| 25. |
J. M. McCord and
I. Fridovich:
Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein).
J. Biol. Chem.
244,
6049-6055 (1969) |
| 26. | R. P. Mason: Assay of in situ radicals by electron spin resonance. Methods Enzymol. 105, 416-422 (1984)[Medline]. |
| 27. | D. R. Duling: Simulation of multiple isotropic spin-trap ESR spectra. J. Magn. Reson. B 104, 105-110 (1994)[Medline]. |
| 28. |
L. S. Harman,
D. K. Carver,
J. Schreiber, and
R. P. Mason:
One- and two-electron oxidation of reduced glutathione by peroxidases.
J. Biol. Chem.
261,
1642-1648 (1986) |
| 29. | C. Mottley, K. Toy, and R. P. Mason: Oxidation of thiol drugs and biochemicals by the lactoperoxidase/hydrogen peroxide system. Mol. Pharmacol. 31, 417-421 (1987)[Abstract]. |
| 30. | G. R. Buettner and R. P. Mason: Spin-trapping methods for detecting superoxide and hydroxyl free radicals in vitro and in vivo. Methods Enzymol. 186, 127-133 (1990)[Medline]. |
| 31. | A. S. W. Li, K. B. Cummings, H. P. Roethling, G. R. Buettner, and C. F. Chignell: A spin-trapping database implemented on the IBM PC/AT. J. Magn. Reson. 79, 140-142 (1988). |
| 32. | L. A. Marquez and H. B. Dunford: Transient and steady-state kinetics of the oxidation of scopoletin by horseradish peroxidase compounds I, II, and III in the presence of NADH. Eur. J. Biochem. 233, 364-371 (1995)[Medline]. |
| 33. | E. Finkelstein, G. M. Rosen, and E. J. Rauckman: Spin trapping. kinetics of the reaction of superoxide and hydroxyl radicals with nitrones. J. Am. Chem. Soc. 102, 4994-4999 (1980). |
| 34. | G. P. Laroff, R. W. Fessenden, and R. H. Schuler: The electron spin resonance spectra of radical intermediates in the oxidation of ascorbic acid and related substances. J. Am. Chem. Soc. 94, 9062-9073 (1972)[Medline]. |
| 35. | H. S. Mason: Mechanisms of oxygen metabolism. Adv. Enzymol. 19, 79 (1957). |
| 36. | T. J. Stone and W. A. Waters: Electron spin resonance spectra of transient aryloxyl and arylamino free radicals. Proc. Chem Soc. (Lond.), 253-254 (1962). |
| 37. | T. J. Stone and W. A. Waters: Aryloxy-radicals. Part I. Electron spin resonance spectra of radicals from some substituted monohydric phenols. J. Chem. Soc. 213-218 (1964). |
| 38. | M. D. Sevilla, M. Yan, and D. Becker: Thiol peroxyl radical formation from the reaction of cysteine thiyl radical with molecular oxygen: an ESR investigation. Biochem. Biophys. Res. Commun. 155, 405-410 (1988)[Medline]. |
| 39. | M. D. Sevilla, M. Yan, D. Becker, and S. Gillich: ESR investigations of the reactions of radiation-produced thiyl and DNA peroxyl radicals: formation of sulfoxyl radicals. Free Radical Res. Commun. 6, 99-102 (1989)[Medline]. |
| 40. | A. Nadezhdin and H. B. Dunford: Oxidation of nicotinamide adenine dinucleotide by hydroperoxyl radical: a flash photolysis study. J. Phys. Chem. 83, 1957-1961 (1979). |
| 41. | R. J. Keller and J. A. Hinson: Mechanism of acetaminophen-stimulated NADPH oxidation catalyzed by the peroxidase-H2O2 system. Drug Metab. Disp. 19, 184-187 (1991)[Abstract]. |
| 42. | J. F. Mouret, M. Polverelli, F. Sarrazini, and J. Cadet: Ionic and radical oxidations of DNA by hydrogen peroxide. Chem. Biol. Interact. 77, 187-201 (1991)[Medline]. |
| 43. |
I. Gimenez-Conti,
A. Viaje,
J. Chesner,
C. Conti, and
T. J. Slaga:
Induction of short-term markers of tumor promotion by organic peroxides.
Carcinogenesis
12,
563-569 (1991) |
| 44. | T. Kensler, K. Guyton, P. Egner, T. McCarthy, S. Lesko, and S. Akman: Role of reactive intermediates in tumor promotion and progression. Prog. Clin. Biol. Res. 391, 103-116 (1995)[Medline]. |
| 45. | U. Giri, S. D. Sharma, M. Abdulla, and M. Athar: Evidence that in situ generated reactive oxygen species act as a potent Stage I tumor promoter in mouse skin. Biochem. Biophys. Res. Commun. 209, 698-705 (1995)[Medline]. |
| 46. | E. Beubler and H. Juan: PGE-Mediated laxative effect of diphenolic laxatives. Nauyn-Schmiedeberg's Arch. Pharmacol. 305, 241-246 (1978)[Medline]. |
| 47. | E. Beubler and H. Juan: Is the effect of diphenolic laxatives mediated via release of prostaglandin E? Experientia 34, 386-387 (1978)[Medline]. |
| 48. | F. Capasso, I. E. Tavares, and A. Bennett: The production of arachidonate lipoxygenase products by rat intestine is increased by phenolphthalein. Eur. J. Pharmacol. 106, 419-422 (1985). |
| 49. | F. Capasso, N. Mascolo, V. Romano, N. Parkinson, and A. Bennett: Potentiation by phenolphthalein of the responses of guinea-pig ileum and rat stomach strip to PGE2 and other agonists. Eur. J. Pharmacol. 145, 1-5 (1988)[Medline]. |
| 50. |
C. M. Markey,
A. Alward,
P. E. Weller, and
L. J. Marnett:
Quantitative studies of hydroperoxide reduction by prostaglandin H synthase.
J. Biol. Chem.
262,
6266-6279 (1987) |
This article has been cited by other articles:
![]() |
P. F. Coogan, L. Rosenberg, J. R. Palmer, B. L. Strom, A. G. Zauber, P. D. Stolley, and S. Shapiro Phenolphthalein Laxatives and Risk of Cancer J Natl Cancer Inst, December 6, 2000; 92(23): 1943 - 1944. [Full Text] [PDF] |
||||
![]() |
B. J. Collins, T. B. Grizzle, and J. K. Dunnick Toxicokinetics of Phenolphthalein in Male and Female Rats and Mice Toxicol. Sci., August 1, 2000; 56(2): 271 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawano and S. Muto Mechanism of peroxidase actions for salicylic acid-induced generation of active oxygen species and an increase in cytosolic calcium in tobacco cell suspension culture J. Exp. Bot., April 1, 2000; 51(345): 685 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Sturgeon, H. J. Sipe Jr., D. P. Barr, J. T. Corbett, J. G. Martinez, and R. P. Mason The Fate of the Oxidizing Tyrosyl Radical in the Presence of Glutathione and Ascorbate. IMPLICATIONS FOR THE RADICAL SINK HYPOTHESIS J. Biol. Chem., November 13, 1998; 273(46): 30116 - 30121. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||